万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

10.3978/j.issn.1000-9604.2014.06.12

Laparoscopic approach for hepatocellular carcinoma: where is the limit?

引用
Hepatocellular cancer (HCC) is the sixth most common malignant tumor worldwide and the most common primary liver cancer (1).Liver resection or liver transplantation is the therapeutic gold standards in patient with HCC.Due to advanced disease,extrahepatic metastases,or inadequate liver reserve,only 15% to 30% of patients with HCC can undergo to surgery (2).Five-year risk of recurrence of HCC after resection is as high as 70% because the underlying chronic liver disease continues to put the patient at risk for the development of new cancer nodules (3).Starting from the assumption that recurrence may be newly treated with surgery,laparoscopic approach is recommended,when applicable,for limiting the abdominal adhesions.

liver transplantation、chronic liver disease、primary liver cancer、malignant tumor

26

R73;R57

2014-08-14(万方平台首次上网日期,不代表论文的发表时间)

共2页

222-223

相关文献
评论
暂无封面信息
查看本期封面目录

中国癌症研究(英文版)

1000-9604

11-2591/R

26

2014,26(3)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn